COX inhibitors and their effects on bone healing

Bibliography

• EINHORN TA: The cell and molecular biology of fracture healing. Clio. Orthop. (1998) 355(Suppi.):S7–S21.
   Google Scholar
• GERSTENFELD LC, CULLINANE DM, BARNES GL, GRAVES DT, TA: Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of regulation.Biochern. (2003)88:873–884.
   Web of Science ®Google Scholar
• ••Current comprehensive review of the basicscience of fracture healing and the effects of various pharmacological compounds on this process.
   Google Scholar
• EINHORN TA, MAJESKA RJ, RUSH EB,LEVINE PM, HOROWITZ MC: expression of cytokine activity by fracture callus. Bone Miner. Res. (1995) 10:1272–1281.
   PubMed Web of Science ®Google Scholar
• NEEDLEMAN P, TURK J, BA, MORRISON AR, LEFKOWITH JB: Arachidonic acid metabolism. Anna. Rev. Biochern. (1986) 55:69–102.
   PubMed Web of Science ®Google Scholar
• ••An extensive review of the PG metabolismand early development of NSAIDs.
   Google Scholar
• XIE W, CHIPMAN JG, ROBERTSON DL, ERIKSON RL, SIMMONS DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA (1991) 89:2692–2696.
   Web of Science ®Google Scholar
• O'BANION MK, WINN VD, YOUNG DA: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sd. USA (1992) 89:4888–4892.
   PubMed Web of Science ®Google Scholar
• RASKIN JB: Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Ana. Med. (1999) 106:S3–S12.
   Google Scholar
• TOPPER JN, CAI J, FALB D, GIMBRONE MA Jr: of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc. Nati Acad. Sci. USA (1996) 93:10417–10422.
   PubMed Web of Science ®Google Scholar
• MUSCARA MN, MCKNIGHT W, ASFAHA S, WALLACE JL: collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br. J. Pharmacol (2000) 129:681–686.
   PubMed Web of Science ®Google Scholar
• HODSMAN NB, BURNS J, BLYTH A, KENNY GN, MCARDLE CS, ROTMAN H: The morphine sparing effects of diclofenac sodium following abdominal surgery. Anaesthesia (1987) 42:1005–1008.
   PubMed Web of Science ®Google Scholar
• MCGLEW IC, ANGLISS DD, GEE GJ, RUTHERFORD A, WOOD AT: A comparison of rectal indomethacin with placebo for pain relief following spinal surgery. Anaesth. Intensive Care (1991) 19:40–45.
   PubMed Web of Science ®Google Scholar
• DUBOIS RN, ABRAMSON SB, CROFFORD L et al.: in biology and disease. FASEB (1998) 12:1063–1073.
   PubMed Web of Science ®Google Scholar
• ••Good review of the biological functionsof C OXs.
   Google Scholar
• LIPSKY PE, BROOKS P, CROFFORD LJ et al.: Unresolved issues in the role of cyclooxygenase-2 in normal physiological processes and disease. Arch. Intern. Med. (2000) 160:913–920.
   PubMed Web of Science ®Google Scholar
• FITZGERALD GA, PATRONO C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl. I Med. (2001) 345:433–442.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of the current status of theclinical uses of coxibs and unresolved questions about their use.
   Google Scholar
• KAWAGUCHI H, PILBEAM CC, HARRISON JR, RAISZ LG: role of prostaglandins in the regulation of bone metabolism. Clin. Orthop. (1995) 313:36–46.
   PubMed Web of Science ®Google Scholar
• ••Relatively recent review of the multiplefunctions of PGs in bone metabolism.
   Google Scholar
• RAISZ LG: Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. J. Med. (2001) 110(Suppl. 3A):435–55.
   Google Scholar
• ••Current review of the effects of coxibs onbone metabolism by one of the foremost experts in the field.
   Google Scholar
• MACHWATE M, HARADA S, LEU CT et al.: Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2 (2001) 60(1):36–41.
   Google Scholar
• JEE WS, MA YF: The in vivo anabolic actions of prostaglandins in bone. Bone (1997) 21:297–304.
   PubMed Web of Science ®Google Scholar
• OKADA Y, LORENZO JA, AM et al.: G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture., " Gin. Invest. (2000) 105:823–832.
   Google Scholar
• LI X, PILBEAM CC, PAN L, BREYER RIVI, RAISZ LG: Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. (2002) 30(4):567–573.
   Google Scholar
• BURGER EH, KLEIN-NULEND J: Microgravity and bone cell mechanosensitivity. Bone (1998) 22\(Suppl. 5):5127–5130.
   Google Scholar
• CHERIAN PP, CHENG B, GUS, SPRAGUE E, BONEWALD LF, JX: Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J. Biol. Chem. (2003) 278(44):43146–43156.
   PubMed Web of Science ®Google Scholar
• SIMON AM, MANIGRASSO MB, O'CONNOR JP: Cyclo-oxygenase-2 function is essential for bone fracture healing. J. Bone Miner. Res. (2002) 17:963–976.
   PubMed Web of Science ®Google Scholar
• EINHORN TA: Do inhibitors of cyclooxygenase-2 impair bone healing? J. Bone Miner. Res. (2002) 17:977–978.
   PubMed Web of Science ®Google Scholar
• ZHANG X, SCHWARZ EM, YOUNG DA, PUZAS JE, ROSIER RN, O'KEEFE RJ: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. Invest. (2002) 109:1405–1415.
   Google Scholar
• ••State-of-the-art animal research definingthe major role that PGs play in bone repair.
   Google Scholar
• ENDO K, SAIRYO K, KOMATSUBARA S et al.: Cyclooxygenase-2 inhibitor inhibits the fracture healing. J. Physic] Anthropol Appl Human ScL (2002) 21:235–238.
   PubMedGoogle Scholar
• GOODMAN S, MA T, TRINDADE M et al.: COX-2 selective NSAID decreases bone ingrowth in vivo. I Orthop. Res. (2002) 20:1164–1169.
   PubMed Web of Science ®Google Scholar
• LONG J, LEWIS S, KUKLO T, ZHU Y, RIEW KD: The effect of cyclooxygenase-2 inhibitors on spinal fusion. J. Bone John-Surg. Am. (2002) 84-A(10):1763–1768.
   Google Scholar
• DUMONT AS, VERMA S, DUMONT RJ, HURLBERT RJ: anti-inflammatory drugs and bone metabolism in spinal fusion surgery: a pharmacological quandary. Toxicol Methods (2000) 43:31–39.
   Google Scholar
• PARALKAR VM, BOROVECKI F, KE HZ et al.: An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc. Natl. Acad. ScL USA (2003) 100(11):6736–6740.
   PubMed Web of Science ®Google Scholar
• AKHTER MP, CULLEN DM, GONG G, RECKER RR: Bone biomechanical properties in prostaglandin EPI and EP2 knockout mice. Bone (2001) 29:121–125.
   PubMed Web of Science ®Google Scholar
• BROWN KM, SAUNDERS MM, KIRSCH T, DONAHUE HJ, REID JS: Effect of COX-2-specific inhibition on fracture-healing in the rat femur. Bone John- Surg. Am. (2004) 86-A(1):116–123.
   Google Scholar
• GERSTENFELD LC, THIEDE M, SEIBERT K et al.: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.," Orthop. Res. (2003) 21:670–675.
   Google Scholar
• GERSTENFELD LC, CULLINANE D, KRALL EA, FITCH J, THIEDE M, EINHORN TA: COX-2 inhibitors and fracture healing: reversibility of effects after short term treatment. Bone Miner. Res. Sapp] (2003) 18:S43.
   Web of Science ®Google Scholar
• GIANNOUDIS PV, MACDONALD DA, MATTHEWS SJ, SMITH RIVI, AJ, DE BOER P: of the femoral diaphysis: the influence of reaming and nonsteroidal anti-inflammatory drugs. I Bone Joint Surg. Br. (2000) 82:655–658.
   PubMed Web of Science ®Google Scholar
• ••One of the few well-defined retrospectivestudies demonstrating potential negative effects of NSAIDS on bone healing.
   Google Scholar
• GLASSMAN SD, ROSE SM, DIMAR JR, PUNO RM, CAMPBELL MJ, JR: The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. (1998) 23:834–838.
   Google Scholar
• ADOLPHSON P, ABBASZADEGAN H, JONSSON U, DALEN N, SJOBERG HE, KALEN S: No effects of piroxicam on osteopenia and recovery after Colles' fracture. Arch. Orthop. Trauma Surg. (1993) 112:127–130.
   PubMed Web of Science ®Google Scholar
• REUBEN SS: Effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion. Reg. Anesth. Pain Med. (2001) 26:590–591.
   PubMed Web of Science ®Google Scholar
• MOORE KD, GOSS K, ANGLEN JO: Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures. I Bone John- Surg. Br. (1998) 80:259–263.
   PubMed Web of Science ®Google Scholar